Found 12 matching trials
A Phase III Clinical Trial Assessing the Immunogenicity and Safety of Lyophilized Live-Attenuated Varicella Vaccine in Healthy Subjects Aged 13 to 55 Years PHASE3 Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Adolesc...
Show More Location
Huaiyin District Center for Disease Control and prevention
Learn More & Join Trial
Serological Evaluation of Varicella and Hepatitis A Vaccines Using Injector Delivery PHASE2 This study aims to assess immunogenicity and safety of nd influence of the ...
Show More Location
Disciplina de Immunologia Clínica e Alergia do HC- FMUSP
Learn More & Join Trial
Immunogenicity and Safety of NBP608 Compared to Varivax in Healthy Children 12 Months to 12 Years of Age PHASE3 This study assesses non-inferiority by comparing seroconversion rate of NBP...
Show More Location
De La Salle Health Sciences Institute
Learn More & Join Trial
Zostavax® at Minimum Release Specification Approaching Expiry (V211-044) PHASE4 Primary objective:
To demonstrate whether or not ZOSTAVAX® at minimum rele...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety Study of NBP608 in Healthy Adult Volunteers PHASE1 * Indication: Protection against varicella and herpes zoster
* Study Object...
Show More Location
Korea University Guro Hospital
Learn More & Join Trial
SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years PHASE3 The goal of this study is to evaluate the safety and immunogenicity of an i...
Show More Learn More & Join Trial
The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age PHASE2 This study evaluates the immunogenicity and safety of three different poten...
Show More Location
Research Insitute for Torpical Medicine
Learn More & Join Trial
Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035) PHASE3 Primary Objective:
* To demonstrate that ProQuad® can be administered conc...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunogenicity and Safety of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over PHASE3 This study assesses non-inferiority by comparing GMR(Geometric Mean Ratio) ...
Show More Location
Korea University Guro Hospital
Learn More & Join Trial
Immunogenicity and Safety of Two Lots of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over PHASE2 This study assesses non-inferiority by comparing GMR(Geometric Mean Ratio) ...
Show More Location
Korea University Guro Hospital
Learn More & Join Trial